Frumil (amiloride and furosemide): Discontinuation

Affected product

Due to low sales globally, Sanofi has decided to stop making Frumil tablets. This is a global discontinuation.

Amiloride hydrochloride with furosemide

• Presentation: Tab 5 mg with furosemide 40 mg
• Brand: Frumil
• Pharmacode: 2125536
• Subsidy: $8.63
• Measure / Qty: per 28

People who take Frumil

If you take Frumil, you will need to talk to the person who prescribes it before the end of February 2026. They will be able to suggest the best alternative for your specific circumstances.

You will need a new prescription. You will need to pay for any appointment or prescription fees.

We acknowledge that it can be disruptive to have to change treatments. However, this decision was made by the supplier, not Pharmac.

People who prescribe Frumil

If you prescribe Frumil, you will need to talk to anyone taking Frumil to discuss a suitable alternative.

Please consider prescribing a funded, Medsafe-registered, alternative for affected people. Amiloride 5 mg tablets are not Medsafe registered and need to be prescribed and dispensed in line with Section 29 of the Medicines Act.  

Schedule listing for funded diuretics(external link)

Diuretics information in the NZ Formulary(external link)

Thank you for the time you take guiding people on changes to treatment. 

Pharmacists

Please advise anyone you dispense Frumil to that this product is being discontinued. They will need to talk to their prescriber about alternative treatment options before the end of February 2026. We have prepared a flyer to support these conversations. 

Thank you for the time you take advising people on discontinuations and other supply issues.

Key dates

31 January 2026 | Sanofi stops supply of Frumil

End February 2026 | Supply of Frumil likely to run out

We will delist Frumil in the future to give time for pharmacies to dispense and claim for Frumil.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)